Pulmonary hypertension (PH) is an established risk factor in patients with atrial septal defect (ASD), and its persistence after ASD closure is associated with increased mortality. Therefore, predictors for PH normalization after defect closure are needed. Multiple hemodynamic types of PH exist, but little is known about their prevalence and prognostic value for PH normalization after ASD closure. We carried out a retrospective study on 97 patients (76% female, median age at ASD closure 58 years) with four types of PH determined predominantly by right heart catheterization: hyperkinetic, pulmonary arterial hypertension, isolated post-capillary, and combined pre- and post-capillary. We investigated the frequency of the PH types and their prognostic significance for PH normalization after ASD closure. Frequency of PH types before ASD closure in our study was: hyperkinetic 55%, pulmonary arterial hypertension 10%, isolated post-capillary PH 24%, and combined PH 11%. Hyperkinetic PH type was positively associated with PH normalization after ASD closure (78% patients normalized), remaining a significant independent predictor when adjusted for age at closure, sex, heart failure, and NYHA. Hyperkinetic PH patients also had significantly better survival prognosis versus patients with other PH types (p = 0.04). Combined PH was negatively associated with PH normalization, with no patients normalizing. Pulmonary arterial hypertension and isolated post-capillary PH had intermediate rates of normalization (60 and 52%, respectively). In summary, all four hemodynamic types of PH are found in adult patients with ASD, and they can be used to stratify patients by their likelihood of PH normalization and survival after ASD closure.

Department of Biochemistry and Molecular Medicine School of Medicine University of California Davis Davis CA United States

Department of Cardiac Surgery Na Homolce Hospital Prague Czechia

Department of Pharmacology School of Medicine University of California Davis Davis CA United States

Pediatric Heart Centre Motol University Hospital Prague Czechia

See more in PubMed

Murphy JG, Gersh BJ, McGoon MD, Mair DD, Porter CJ, Ilstrup DM, et al. . Long-term outcome after surgical repair of isolated atrial septal defect. N Engl J Med. (1990) 323:1645–50. 10.1056/NEJM199012133232401 PubMed DOI

Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. . 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. (2016) 37:67–119. 10.1016/j.rec.2016.01.002 PubMed DOI

Engelfriet P, Meijboom F, Boersma E, Tijssen J, Mulder B. Repaired and open atrial septal defects type II in adulthood: an epidemiological study of a large European cohort. Int J Cardiol. (2008) 126:379–85. 10.1016/j.ijcard.2007.04.044 PubMed DOI

Gabriels C, De Meester P, Pasquet A, De Backer J, Paelinck BP, Morissens M, et al. . A different view on predictors of pulmonary hypertension in secundum atrial septal defect. Int J Cardiol. (2014). 10.1016/j.ijcard.2014.08.009 PubMed DOI

Akseer S, Abrahamyan L, Lee DS, Huszti E, Meier LM, Osten M, et al. . Long-term outcomes in adult patients with pulmonary hypertension after percutaneous closure of atrial septal defects. Circ Cardiovasc Interv. (2022) 15:e011110. 10.1161/CIRCINTERVENTIONS.121.011110 PubMed DOI

Rubáčková Popelová J, Tomková M, Tomek J, Živná R. Long-term survival of adult patients with atrial septal defect with regards to defect closure and pulmonary hypertension. Front Cardiovasc Med. 9:867012. 10.3389/fcvm.2022.867012 PubMed DOI PMC

Ranard LS, Mallah WE, Awerbach JD, Abernethy A, Halane M, Qureshi AM, et al. . Impact of pulmonary hypertension on survival following device closure of atrial septal defects. Am J Cardiol. (2019) 124:1460–4. 10.1016/j.amjcard.2019.07.042 PubMed DOI

Lammers AE, Bauer LJ, Diller GP, Helm PC, Abdul-Khaliq H, Bauer UMM, et al. . Pulmonary hypertension after shunt closure in patients with simple congenital heart defects. Int J Cardiol. (2020) 308:28–32. 10.1016/j.ijcard.2019.12.070 PubMed DOI

Opotowsky AR. Clinical evaluation and management of pulmonary hypertension in the adult with congenital heart disease. Circulation. (2015) 131:200–10. 10.1161/CIRCULATIONAHA.114.006976 PubMed DOI

Jain S, Dalvi B. Atrial septal defect with pulmonary hypertension: when/how can we consider closure? J Thorac Dis. (2018) 10:S2890–8. 10.21037/jtd.2018.07.112 PubMed DOI PMC

Baumgartner H, Bonhoeffer P, De Groot NMSS, de Haan F, Deanfield JE, Galie N, et al. . ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J. (2010) 31:2915–57. 10.1016/j.repce.2012.05.004 PubMed DOI

Baumgartner H, De Backer J, Babu-Narayan SV, Budts W, Chessa M, Diller G-P, et al. . 2020 ESC Guidelines for the management of adult congenital heart disease: the Task Force for the management of adult congenital heart disease of the European Society of Cardiology (ESC). Eur Heart J. (2020) 42:ehaa554. 10.15829/1560-4071-2021-4702 PubMed DOI

Van Der Feen DE, Bartelds B, De Boer RA, Berger RMF. Assessment of reversibility in pulmonary arterial hypertension and congenital heart disease. Heart. (2019) 105:276–82. 10.1136/heartjnl-2018-314025 PubMed DOI

Van Riel ACMJ, Schuuring MJ, Van Hessen ID, Zwinderman AH, Cozijnsen L, Reichert CLA, et al. . Contemporary prevalence of pulmonary arterial hypertension in adult congenital heart disease following the updated clinical classification. Int J Cardiol. (2014) 174:299–305. 10.1016/j.ijcard.2014.04.072 PubMed DOI

Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, et al. . Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. (2019) 53:1801913. 10.1183/13993003.01913-2018 PubMed DOI PMC

Yong G, Khairy P, De Guise P, Dore A, Marcotte F, Mercier LA, et al. . Pulmonary arterial hypertension in patients with transcatheter closure of secundum atrial septal defects a longitudinal study. Circ Cardiovasc Interv. (2009) 2:455–62. 10.1161/CIRCINTERVENTIONS.108.826560 PubMed DOI

Wood P. The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt. Br Med J. (1958) 2:755–62. 10.1136/bmj.2.5099.755 PubMed DOI PMC

Newman JH. Pulmonary hypertension by the method of Paul Wood. Chest. (2020) 158:1164–1171. 10.1016/j.chest.2020.02.035 PubMed DOI

Humenberger M, Rosenhek R, Gabriel H, Rader F, Heger M, Klaar U, et al. . Benefit of atrial septal defect closure in adults: impact of age. Eur Heart J. (2011) 32:553–560. 10.1093/eurheartj/ehq352 PubMed DOI PMC

Parasuraman S, Walker S, Loudon BL, Gollop ND, Wilson AM, Lowery C, et al. . Assessment of pulmonary artery pressure by echocardiography-A comprehensive review. Int J Cardiol Hear Vasc. (2016) 12:45–51. 10.1016/j.ijcha.2016.05.011 PubMed DOI PMC

Abbas AE, Franey LM, Marwick T, Maeder MT, Kaye DM, Vlahos AP, et al. . Noninvasive assessment of pulmonary vascular resistance by Doppler echocardiography. J Am Soc Echocardiogr. (2013) 26:1170–7. 10.1016/j.echo.2013.06.003 PubMed DOI

Aduen JF, Castello R, Lozano MM, Hepler GN, Keller CA, Alvarez F, et al. . An alternative echocardiographic method to estimate mean pulmonary artery pressure: diagnostic and clinical implications. J Am Soc Echocardiogr. (2009) 22:814–819. 10.1016/j.echo.2009.04.007 PubMed DOI

Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. (1994) 81:515. 10.1093/biomet/81.3.515 DOI

Zwijnenburg RD, Baggen VJM, Witsenburg M, Boersma E, Roos-Hesselink JW, van den Bosch AE. Risk factors for pulmonary hypertension in adults after atrial septal defect closure. Am J Cardiol. (2019) 123:1336–42. 10.1016/j.amjcard.2019.01.011 PubMed DOI

D'Alto M, Romeo E, Argiento P, Correra A, Santoro G, Gaio G, et al. . Hemodynamics of patients developing pulmonary arterial hypertension after shunt closure. Int J Cardiol. (2013) 168:3797–3801. 10.1016/j.ijcard.2013.06.036 PubMed DOI

Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, et al. . ACC/AHA 2008 guidelines for the management of adults with congenital heart disease. J Am Coll Cardiol. (2008) 52:1890–1947. 10.1016/j.jacc.2008.10.001 PubMed DOI

Assad TR, Hemnes AR, Larkin EK, Glazer AM, Xu M, Wells QS, et al. . Clinical and biological insights into combined post- and pre-capillary pulmonary hypertension. J Am Coll Cardiol. (2016) 68:2525–2536. 10.1016/j.jacc.2016.09.942 PubMed DOI PMC